| 000 -LEADER |
|---|
| fixed length control field |
01433 a2200301 4500 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
041203s xx 000 0 eng |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER |
|---|
| International Standard Serial Number |
1522-3264; |
| 050 ## - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
AC1.S5 |
| 082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
050 |
| 100 ## - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Becker, T.J., |
| 245 #0 - TITLE STATEMENT |
|---|
| Title |
3-D Modeling. |
| Statement of responsibility, etc. |
T.J. Becker. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Name of publisher, distributor, etc. |
Research Horizons, |
| Date of publication, distribution, etc. |
2004. |
| 440 ## - SERIES STATEMENT/ADDED ENTRY--TITLE |
|---|
| Title |
SIRS Enduring Issues 2005. |
| Number of part/section of a work |
Article 70, |
| Name of part/section of a work |
Science, |
| International Standard Serial Number |
1522-3264; |
| 500 ## - GENERAL NOTE |
|---|
| General note |
Articles Contained in SIRS Enduring Issues 2005. |
| 500 ## - GENERAL NOTE |
|---|
| General note |
Originally Published: 3-D Modeling, Spring/Summer 2004; pp. 23-26. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
"Researchers currently rely on animal models and two dimensional (2-D) cultures of human cells to study cancer and test potential drugs. Yet these models have two major problems: Human cells behave differently in a 2-D environment than their natural 3-D state, and animal physiology isn't the same as humans." (RESEARCH HORIZONS) This article describes the use of 3-D modeling in the study of prostate cancer. |
| 599 ## - |
|---|
| -- |
Records created from non-MARC resource. |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Boron-neutron capture therapy |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Cancer |
| General subdivision |
Radiotherapy |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Cancer |
| General subdivision |
Research |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Cancer |
| General subdivision |
Treatment |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Oncogenic viruses |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Radiation |
| General subdivision |
Dosage |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Three-dimensional imaging in medicine |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Viral therapy |
| 710 ## - ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
ProQuest Information and Learning Company |
| Title of a work |
SIRS Enduring Issues 2005, |
| Name of part/section of a work |
Science. |
| International Standard Serial Number |
1522-3264; |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Koha item type |
|
